NFSG
CRBP icon

Newbridge Financial Services Group’s Corbus Pharmaceuticals CRBP Stock Holding History

Newbridge Financial Services Group’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$150 Buy
+16
New +$135 ﹤0.01% 1142
2021
Q4 		– Sell
-367
Closed -$11K – 1432
2021
Q3 		$11K Buy
+367
New +$14.5K 0.01% 841

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $588M AUM 182.75% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Newbridge Financial Services Group's CRBP Position: Q1 2026 in Review

Newbridge Financial Services Group opened a new position in Corbus Pharmaceuticals (CRBP) in Q1 2026: 16 shares worth $150. The stake represents ﹤0.01% of the portfolio and ranks #1142 among its holdings. This is a return to the name: Newbridge Financial Services Group previously reported a position in CRBP as recently as Q3 2021.

Newbridge Financial Services Group first reported a position in CRBP in Q3 2021 and has held it in 2 quarters since. The position peaked at $11K in Q3 2021. 107 funds tracked by Wall St. Rank hold CRBP as of Q1 2026.

  • Newbridge Financial Services Group held 16 shares of Corbus Pharmaceuticals worth $150 as of Q1 2026.
  • Corbus Pharmaceuticals was a new Newbridge Financial Services Group position in Q1 2026.
  • Corbus Pharmaceuticals made up ﹤0.01% of Newbridge Financial Services Group's portfolio in Q1 2026, its #1142 holding.
  • Newbridge Financial Services Group first reported a position in Corbus Pharmaceuticals in Q3 2021 and has held it in 2 quarters since.
  • Newbridge Financial Services Group's Corbus Pharmaceuticals position peaked at $11K in Q3 2021.
  • 107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q1 2026.

Based on Newbridge Financial Services Group's 13F filing for Q1 2026, filed 5 May 2026.